Get the Stockscreener App
3.395
1.88%
-0.065
Imunon Inc stock is traded at $3.395, with a volume of 18,384.
It is down -1.88% in the last 24 hours and up +10.59% over the past month.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
See More
Previous Close:
$3.46
Open:
$3.56
24h Volume:
18,384
Relative Volume:
0.40
Market Cap:
$11.29M
Revenue:
$125.00K
Net Income/Loss:
$-15.75M
P/E Ratio:
-0.5536
EPS:
-6.1327
Net Cash Flow:
$-14.57M
1W Performance:
+7.44%
1M Performance:
+10.59%
6M Performance:
-41.01%
1Y Performance:
-70.42%
1-Day Range:
$3.32
$3.58
1-Week Range:
$3.06
$3.59
52-Week Range:
$2.99
$41.22
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
3.32 | 11.77M | 125.00K | -15.75M | -14.57M | -6.1327 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Imunon Inc Stock (IMNN) Latest News
Targets Report: Will Imunon Inc outperform tech stocksJuly 2025 Final Week & High Conviction Investment Ideas - baoquankhu1.vn
Market Overview: Is Imunon Inc a defensive stock2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IMNN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMNN SEC FilingsImunon Inc 10-K, 10-Q, 8-K Forms - Stock Titan
IMNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Imunon Inc expected to post a loss of $1.17 a shareEarnings Preview - TradingView
What risks investors should watch in Imunon Inc. stockWeekly Profit Report & Risk Controlled Swing Alerts - mfd.ru
Can Imunon Inc continue delivering strong returnsJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Will Imunon Inc. outperform small cap indexesWeekly Risk Report & Free Community Supported Trade Ideas - mfd.ru
Will Imunon Inc. outperform tech stocksQuarterly Trade Report & Technical Entry and Exit Alerts - mfd.ru
Should I invest in Imunon Inc. before earningsIPO Watch & Consistent Profit Trade Alerts - mfd.ru
FY2025 Earnings Estimate for Imunon Issued By HC Wainwright - Defense World
Imunon stock price target raised to $25 from $14 at H.C. Wainwright By Investing.com - Investing.com South Africa
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Oncolytics Biotech (ONCY) and Imunon (IMNN) - The Globe and Mail
IMNN: Streamlining Operations to Focus on OVATION 3 - Smartkarma
Rate Hike: Will Imunon Inc outperform its industry peersJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Imunon stock price target raised to $25 from $14 at H.C. Wainwright - Investing.com Australia
Imunon, Inc. Announces Retirement of Executive Vice President and Chief Scientific Officer Khursheed Anwer, Effective February 20, 2026 - marketscreener.com
Imunon sharpens focus on its promising pivotal Phase 3 ovarian cancer study - marketscreener.com
IMUNON rises on plan to shift resources to ovarian cancer therapy - TradingView
Imunon stock rises following strategic restructuring to focus on Phase 3 trial - Investing.com Nigeria
Imunon stock rises following strategic restructuring to focus on Phase 3 trial By Investing.com - Investing.com South Africa
Imunon announces orderly retirement of chief scientific officer - TipRanks
IMUNON, Inc. Announces Strategic Restructuring and Retirement of Chief Scientific Officer to Advance Phase 3 Clinical Trial - Quiver Quantitative
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY - One News Page
Imunon Sharpens Focus On Its Promising Pivotal Phase 3 Ovarian Cancer Study - TradingView
Resistance Check: Is MLTX stock a buy or sellGold Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Stock Analysis: Can Imunon Inc sustain earnings growthTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Imunon CEO says ‘poised for key milestones’ as company enters 2026 - MSN
Pullback Watch: Can Imunon Inc continue delivering strong returnsQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Mood: What is Franklin BSP Realty Trust Incs debt to equity ratioPortfolio Gains Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Is Imunon Inc. stock a good pick for beginnersQuarterly Earnings Summary & Verified Momentum Watchlists - bollywoodhelpline.com
IPO Launch: Why Imunon Inc stock is recommended by analystsJuly 2025 Volume & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Aug Weekly: What is Five Below Incs revenue forecastPortfolio Performance Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Head to Head Review: Allogene Therapeutics (NASDAQ:ALLO) and Imunon (NASDAQ:IMNN) - Defense World
Market Review: Will Imunon Inc stock deliver shareholder valueWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Imunon, Inc. (NASDAQ:IMNN) Receives $232.50 Average Price Target from Analysts - Defense World
Can Imunon Inc. stock maintain growth trajectoryMarket Movement Recap & Daily Entry Point Trade Alerts - Улправда
How Imunon Inc. stock performs in stagflationChart Signals & Expert Approved Momentum Trade Ideas - Улправда
Will Imunon Inc. stock deliver shareholder valueMarket Rally & Risk Controlled Stock Pick Alerts - Улправда
Can Imunon Inc. stock attract ESG capital inflowsQuarterly Trade Summary & High Conviction Buy Zone Picks - Улправда
Imunon Announces CFO Transition and Reappointment of Jeffrey Church - The Globe and Mail
Imunon IncInterim CFO Kimberly Graper To Resign January 14, 2026SEC Filing - TradingView — Track All Markets
Imunon, Inc. Announces CFO Transition - TradingView — Track All Markets
Imunon, Inc. Announces Executive Changes, Effective January 14, 2026 - marketscreener.com
Brookline Capital lowers Imunon stock price target to $16 on offering dilution By Investing.com - Investing.com Nigeria
Brookline Capital lowers Imunon stock price target to $16 on offering dilution - Investing.com Nigeria
Market Trends: Can Imunon Inc stock deliver surprise earnings beatWeekly Risk Report & Daily Risk Controlled Trade Plans - Bộ Nội Vụ
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices - MSN
Imunon Announces $7 Million Registered Direct Offering - TipRanks
Imunon Signs Securities Purchase Agreement With Undisclosed Healthcare-Focused Institutional Investor - TradingView — Track All Markets
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):